Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits
- PMID: 24080471
- DOI: 10.1016/j.pharmthera.2013.09.006
Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits
Abstract
N-acetyl-l-cysteine (NAC) has long been used therapeutically for the treatment of acetaminophen (paracetamol) overdose, acting as a precursor for the substrate (l-cysteine) in synthesis of hepatic glutathione (GSH) depleted through drug conjugation. Other therapeutic uses of NAC have also emerged, including the alleviation of clinical symptoms of cystic fibrosis through cysteine-mediated disruption of disulfide cross-bridges in the glycoprotein matrix in mucus. More recently, however, a wide range of clinical studies have reported on the use of NAC as an antioxidant, most notably in the protection against contrast-induced nephropathy and thrombosis. The results from these studies are conflicting and a consensus is yet to be reached regarding the merits or otherwise of NAC in the antioxidant setting. This review seeks to re-evaluate the mechanism of action of NAC as a precursor for GSH synthesis in the context of its activity as an "antioxidant". Results from recent studies are examined to establish whether the pre-requisites for effective NAC-induced antioxidant activity (i.e. GSH depletion and the presence of functional metabolic pathways for conversion of NAC to GSH) have received adequate consideration in the interpretation of the data. A key conclusion is a reinforcement of the concept that NAC should not be considered to be a powerful antioxidant in its own right: its strength is the targeted replenishment of GSH in deficient cells and it is likely to be ineffective in cells replete in GSH.
Keywords: AKI; Antioxidant; BAL; CF; CIN; COPD; GCL; GSH; GSH Px; GSSG; Glutathione; IPF; IV; N-acetyl-l-cysteine; N-acetylcysteine; N-aceytl-p-benzoquinonimine; NAC; NAPQI; ROS; acute kidney injury; bronchoalveolar lavage; chronic obstructive pulmonary disease; contrast-induced nephropathy; cystic fibrosis; glutamate cysteine ligase; glutathione; glutathione disulfide; glutathione peroxidises; idiopathic pulmonary fibrosis; intravenous; reactive oxygen species.
© 2013.
Similar articles
-
A minireview on N-acetylcysteine: An old drug with new approaches.Life Sci. 2016 Apr 15;151:359-363. doi: 10.1016/j.lfs.2016.03.003. Epub 2016 Mar 2. Life Sci. 2016. PMID: 26946308 Review.
-
Oxidation pathway and exacerbations in COPD: the role of NAC.Expert Rev Respir Med. 2016;10(1):89-97. doi: 10.1586/17476348.2016.1121105. Epub 2015 Dec 15. Expert Rev Respir Med. 2016. PMID: 26567752 Review.
-
Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats.Eur J Pharmacol. 2010 Dec 15;649(1-3):224-8. doi: 10.1016/j.ejphar.2010.09.035. Epub 2010 Sep 22. Eur J Pharmacol. 2010. PMID: 20868666
-
Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity.J Cardiovasc Pharmacol. 2009 Oct;54(4):319-26. doi: 10.1097/FJC.0b013e3181b6e77b. J Cardiovasc Pharmacol. 2009. PMID: 19668088
-
The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine.Toxicology. 2004 Aug 5;200(2-3):193-203. doi: 10.1016/j.tox.2004.03.016. Toxicology. 2004. PMID: 15212815
Cited by
-
Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection.Int J Mol Sci. 2024 May 17;25(10):5449. doi: 10.3390/ijms25105449. Int J Mol Sci. 2024. PMID: 38791487 Free PMC article. Review.
-
Comparative Analysis of Epigallocatechin-3-Gallate and TNF-Alpha Inhibitors in Mitigating Cisplatin-Induced Pancreatic Damage Through Oxidative Stress and Apoptosis Pathways.Biol Trace Elem Res. 2024 May 22. doi: 10.1007/s12011-024-04239-9. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38776022
-
The emerging role of regulated cell death in ischemia and reperfusion-induced acute kidney injury: current evidence and future perspectives.Cell Death Discov. 2024 May 4;10(1):216. doi: 10.1038/s41420-024-01979-4. Cell Death Discov. 2024. PMID: 38704372 Free PMC article. Review.
-
The effects of antioxidant supplementation on short-term mortality in sepsis patients.Heliyon. 2024 Apr 4;10(8):e29156. doi: 10.1016/j.heliyon.2024.e29156. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38644822 Free PMC article.
-
Ferroptosis in Cardiovascular Disease and Cardiomyopathies: Therapeutic Implications of Glutathione and Iron Chelating Agents.Biomedicines. 2024 Mar 1;12(3):558. doi: 10.3390/biomedicines12030558. Biomedicines. 2024. PMID: 38540171 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical